glp 1 agonist metformin New aspects of an old drug: as a glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia Therapeutic Potential of Glucagon-like Peptide-1
Description
GIP/GLP-1 Dual Agonists The research shows that tirzepatide outperforms semaglutide at both weight loss and blood sugar control

Studies show that GLP-1s decrease pain/stiffness, protect cartilage, and improve mobility, possibly preventing surgery for some

The powder is reconstituted with the diluent before administration, yielding a yellow solution stabilized by excipients such as mannitol, polysorbate 80, sodium phosphate, and trehalose dihydrate

Peer review Peer review information Nature Reviews Rheumatology thanks Helena Marzo-Ortega, who co-reviewed with Jacob Williams

Across analyses, a recurring contrast is observed between (i) a reproductive subtypeoften reported as higher LH and SHBG with elevated androgens despite comparatively lower BMI and fasting insulinand (ii) a metabolic subtype, characterized by higher adiposity with higher glucose/insulin measures and lower SHBG (and, in some reports, lower LH) ( n = 11,908), four sub-phenotypes were identified, broadly echoing this metabolicreproductive axis and showing substantial overlap with NIH-based subtyping frameworks ( From a reproductive endocrine perspective, canonical PCOS is characterized by: (i) hyperandrogenism, presenting as hirsutism, acne, and androgenetic alopecia, with elevated total/free testosterone, an increased free androgen index (FAI), and occasionally elevated dehydroepiandrosterone sulfate (DHEAS)

The greatest reward in my specialty is celebrating personal victories with my patients when they reach their health goals, Dr
